Ihor Boszko joined SickKids as Executive Director of the Industry Partnerships & Commercialization team in November 2018, bringing close to two decades of experience in the life sciences sector. Previously, Ihor spent nearly fifteen years in the in vitro diagnostics industry developing, commercializing and partnering innovative molecular diagnostic technologies at Tm Bioscience (TSXV: TMC), Luminex (NASDAQ: LMNX) and venture-backed start-up Xagenic. He currently sits on the Board of Directors of Radiant Biotherapeutics and is a Director of CELS-SFO.
Industry Partnerships & Commercialization
SickKids IP&C office champions the identification, development and commercialization of cutting-edge health research, technology and innovations developed by scientists and clinicians.